Clinical and Radiographic Evaluation of 3Mix and Vitapex as Pulpectomy Medicament in Primary Molars: An
3Mix
Lesion sterilization and tissue repair care
Nonvital pulp treatment
Primary teeth
Vitapex
Journal
International journal of clinical pediatric dentistry
ISSN: 0974-7052
Titre abrégé: Int J Clin Pediatr Dent
Pays: India
ID NLM: 101585405
Informations de publication
Date de publication:
Historique:
entrez:
23
5
2020
pubmed:
23
5
2020
medline:
23
5
2020
Statut:
ppublish
Résumé
To evaluate the clinical and radiographic success rates of 3Mix and Vitapex in the treatment of necrosed primary teeth. Seventy teeth of healthy children aged 4-9 years with necrotic primary molar (nonvital) were treated with 3Mix (lesion sterilization tissue repair therapy) and Vitapex before restoration with stainless steel crowns. The participants were followed up clinically and radiographically for 3 months and 6 months, respectively. The outcome was compared using Fisher exact test with a significance level of Clinical success rate of 3Mix group at 3 months and 6 month follow-up was 100% and 97.14% and that of Vitapex group was 100% and 100%, respectively. The radiographic success rate of 3Mix group at 3 months and 6 months was 74.29% and 77.14% and of Vitapex group was 97.14% and 97.14%, respectively. Considering the clinical success, no statistical difference was found between the two groups at the end of 6 month ( Non-instrumentation endodontic treatment using 3Mix has shown a good clinical success of 97.14% but the radiographic success rate at 6 months was lower (77.14%). So it can be suggested that the use of 3Mix antibiotic treatment cannot replace conventional root canal treatment over the long term. Rai R, Shashibhusan KK, Babaji P,
Identifiants
pubmed: 32440070
doi: 10.5005/jp-journals-10005-1686
pmc: PMC7229390
doi:
Types de publication
Journal Article
Langues
eng
Pagination
532-537Informations de copyright
Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.
Déclaration de conflit d'intérêts
Source of support: Nil Conflict of interest: None
Références
Int Endod J. 1996 Mar;29(2):118-24
pubmed: 9206435
J Indian Soc Pedod Prev Dent. 2008 Jan;26 Suppl 1:S5-10
pubmed: 18974537
Am J Dent. 2005 Dec;18(6):347-50
pubmed: 16433405
Int J Paediatr Dent. 2010 May;20(3):214-21
pubmed: 20409203
Int J Paediatr Dent. 2012 May;22(3):217-27
pubmed: 21951271
Int Endod J. 2004 Feb;37(2):132-8
pubmed: 14871180
Chemotherapy. 2001 May-Jun;47(3):203-7
pubmed: 11306789
Int Endod J. 2002 Apr;35(4):330-6
pubmed: 12059933
J Indian Soc Pedod Prev Dent. 2011 Apr-Jun;29(2):121-7
pubmed: 21911950
Pediatr Dent. 2000 Nov-Dec;22(6):517-20
pubmed: 11132515
J Clin Pediatr Dent. 1999 Summer;23(4):289-94
pubmed: 10551129
Int J Paediatr Dent. 2004 Nov;14(6):417-24
pubmed: 15525310
J Oral Biol Craniofac Res. 2014 May-Aug;4(2):114-9
pubmed: 25737928